Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junsung Choi

Showing results (21-30 of 48) with videos related to

Pageof 5
Sort By:
Journal of Vascular and Interventional Radiology : JVIR|June 15, 2020
Transarterial Radioembolization Treatment of Pancreatic Cancer Patients with Liver-Dominant Metastatic Disease Using Yttrium-90 Glass Microspheres: A Single-Institution Retrospective StudyRoger Kayaleh, Hailey Krzyston, Anupam Rishi, et al.
Cancer Control : Journal of the Moffitt Cancer Center|October 5, 2017
Multimodality Management of "Borderline Resectable" Pancreatic Neuroendocrine Tumors: Report of a Single-Institution ExperienceChenwi M Ambe, Phuong Nguyen, Barbara A Centeno, et al.
Annals of Surgical Oncology|August 22, 2024
Hepatic and Overall Progression-Free Survival After Percutaneous Hepatic Perfusion (PHP) as First-Line or Second-Line Therapy for Metastatic Uveal MelanomaHelana Ghali, Michelle M Dugan, Shaliz Aflatooni, et al.
Journal of Vascular and Interventional Radiology : JVIR|May 20, 2023
Radioembolization with Yttrium-90 Glass Microspheres as a First-Line Treatment for Unresectable Intrahepatic Cholangiocarcinoma-A Prospective Feasibility StudyBela Kis, Ravi Shridhar, Rahul Mhaskar, et al.
Journal of Gastrointestinal Oncology|December 4, 2018
Using the Albumin-Bilirubin (ALBI) grade as a prognostic marker for radioembolization of hepatocellular carcinomaHoman Mohammadi, Yazan Abuodeh, William Jin, et al.
American Journal of Clinical Oncology|January 7, 2017
Hepatic Progression-free and Overall Survival After Regional Therapy to the Liver for Metastatic MelanomaAndrea M Abbott, Matthew P Doepker, Youngchul Kim, et al.
Cardiovascular and Interventional Radiology|June 16, 2012
Chemosaturation with percutaneous hepatic perfusion for unresectable isolated hepatic metastases from sarcomaJeremiah L Deneve, Junsung Choi, Ricardo J Gonzalez, et al.
Surgical Endoscopy|January 30, 2015
Comparative long-term outcomes of upfront resected pancreatic cancer after preoperative biliary drainageTobin J Strom, Jason B Klapman, Gregory M Springett, et al.
Journal of the American College of Surgeons|March 26, 2013
Quantitative measures of visceral adiposity and body mass index in predicting rectal cancer outcomes after neoadjuvant chemoradiationWhalen Clark, Erin M Siegel, Y Ann Chen, et al.
Cardiovascular and Interventional Radiology|July 27, 2021
Role of Radioembolization in the Management of Liver-Dominant Metastatic Renal Cell Carcinoma: A Single-Center, Retrospective StudyAndras Bibok, Rahul Mhaskar, Rohit Jain, et al.
Pageof 5

Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
Journal of Vascular and Interventional Radiology : JVIR|June 15, 2020
Transarterial Radioembolization Treatment of Pancreatic Cancer Patients with Liver-Dominant Metastatic Disease Using Yttrium-90 Glass Microspheres: A Single-Institution Retrospective StudyRoger Kayaleh, Hailey Krzyston, Anupam Rishi, et al.
Cancer Control : Journal of the Moffitt Cancer Center|October 5, 2017
Multimodality Management of "Borderline Resectable" Pancreatic Neuroendocrine Tumors: Report of a Single-Institution ExperienceChenwi M Ambe, Phuong Nguyen, Barbara A Centeno, et al.
Annals of Surgical Oncology|August 22, 2024
Hepatic and Overall Progression-Free Survival After Percutaneous Hepatic Perfusion (PHP) as First-Line or Second-Line Therapy for Metastatic Uveal MelanomaHelana Ghali, Michelle M Dugan, Shaliz Aflatooni, et al.
Journal of Vascular and Interventional Radiology : JVIR|May 20, 2023
Radioembolization with Yttrium-90 Glass Microspheres as a First-Line Treatment for Unresectable Intrahepatic Cholangiocarcinoma-A Prospective Feasibility StudyBela Kis, Ravi Shridhar, Rahul Mhaskar, et al.
Journal of Gastrointestinal Oncology|December 4, 2018
Using the Albumin-Bilirubin (ALBI) grade as a prognostic marker for radioembolization of hepatocellular carcinomaHoman Mohammadi, Yazan Abuodeh, William Jin, et al.
American Journal of Clinical Oncology|January 7, 2017
Hepatic Progression-free and Overall Survival After Regional Therapy to the Liver for Metastatic MelanomaAndrea M Abbott, Matthew P Doepker, Youngchul Kim, et al.
Cardiovascular and Interventional Radiology|June 16, 2012
Chemosaturation with percutaneous hepatic perfusion for unresectable isolated hepatic metastases from sarcomaJeremiah L Deneve, Junsung Choi, Ricardo J Gonzalez, et al.
Surgical Endoscopy|January 30, 2015
Comparative long-term outcomes of upfront resected pancreatic cancer after preoperative biliary drainageTobin J Strom, Jason B Klapman, Gregory M Springett, et al.
Journal of the American College of Surgeons|March 26, 2013
Quantitative measures of visceral adiposity and body mass index in predicting rectal cancer outcomes after neoadjuvant chemoradiationWhalen Clark, Erin M Siegel, Y Ann Chen, et al.
Cardiovascular and Interventional Radiology|July 27, 2021
Role of Radioembolization in the Management of Liver-Dominant Metastatic Renal Cell Carcinoma: A Single-Center, Retrospective StudyAndras Bibok, Rahul Mhaskar, Rohit Jain, et al.
Pageof 5